FDA vs. The Group of Progressive Interstitial Lung Diseases
The U.S. Food and Drug Administration now signed Ofev (nintedanib) oral capsules to manage the sufferers with chronic fibrosing (scarring) interstitial lung diseases (ILD) with…
The U.S. Food and Drug Administration now signed Ofev (nintedanib) oral capsules to manage the sufferers with chronic fibrosing (scarring) interstitial lung diseases (ILD) with…
The U.S. Food and Drug Administration has established an application for the first generic of Daraprim (pyrimethamine) pills for the treatment of toxoplasmosis (an infection…
Esperion bempedoic acid (Nexletol) tablet has gained FDA approval for use in lowering low-density lipoprotein cholesterol (LDL-C) in adults with heterozygous familial hypercholesterolemia (HeFH) or…
The U.S. Food and Drug Administration (FDA) has accepted the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the therapy or blocking of…
On June 25, the United States Food and Drug Administration (FDA) approved the first medication based on marijuana (Cannabis sativa plant). The purpose of this…
According to the National Institutes of Health (NIH), about one million of people in the United States have Parkinson’s disease and about 60,000 people are…
On March 1, the Food and Drug Administration (FDA) approved Odactra, a drug developed to treat house dust mite (HDM) allergies. The medication is manufactured…
Spinraza was developed by Ionis Pharmaceuticals of Carlsbad in partnership with Biogen Inc. In July 2016, Biogen decided to license Spinraza. During Spinraza’s development, Ionis…
According to the Centers for Disease Control and Prevention, about 15,000 people die each year from overdoses caused by prescription medication. Painkillers are the top…
Another medication, called Qsymia, designed for obesity treatment and considered to be the most effective among the new generation of weight-loss drugs, was approved by…